Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS.
Adult
Aged
Aging
/ pathology
Cohort Studies
Disease Progression
Female
Humans
Longitudinal Studies
Magnetic Resonance Imaging
/ trends
Male
Middle Aged
Multiple Sclerosis
/ diagnostic imaging
Retinal Ganglion Cells
/ pathology
Retinal Photoreceptor Cell Inner Segment
/ pathology
Retrospective Studies
Tomography, Optical Coherence
/ trends
Young Adult
Journal
Neurology(R) neuroimmunology & neuroinflammation
ISSN: 2332-7812
Titre abrégé: Neurol Neuroimmunol Neuroinflamm
Pays: United States
ID NLM: 101636388
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
entrez:
28
8
2019
pubmed:
28
8
2019
medline:
25
9
2020
Statut:
epublish
Résumé
To investigate whether inner nuclear layer (INL) thickness as assessed with optical coherence tomography differs between patients with progressive MS (P-MS) according to age and disease activity. In this retrospective longitudinal analysis, differences in terms of peripapillary retinal nerve fiber layer (pRNFL), ganglion cell layer + inner plexiform layer (GCIPL), INL and T1/T2 lesion volumes (T1LV/T2LV) were assessed between 84 patients with P-MS and 36 sex- and age-matched healthy controls (HCs) and between patients stratified according to age (cut-off: 51 years) and evidence of clinical/MRI activity in the previous 12 months RESULTS: pRNFL and GCIPL thickness were significantly lower in patients with P-MS than in HCs ( INL thickness was higher in younger patients with P-MS with recent MRI activity, a criterion used in previous studies to identify a specific subset of patients with P-MS who best responded to disease-modifying treatment. If this finding is confirmed, we suggest that INL thickness might be a useful tool in stratification of patients with P-MS for current and experimental treatment choice.
Identifiants
pubmed: 31454778
pii: 6/5/e596
doi: 10.1212/NXI.0000000000000596
pmc: PMC6705649
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Références
Ann Neurol. 2009 Oct;66(4):460-71
pubmed: 19847908
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Lancet Neurol. 2012 Nov;11(11):963-72
pubmed: 23041237
Invest Ophthalmol Vis Sci. 2013 Jul 22;54(7):4934-40
pubmed: 23761080
Neurology. 2014 Jul 15;83(3):278-86
pubmed: 24871874
Mult Scler. 2015 Feb;21(2):163-70
pubmed: 24948688
Mult Scler. 2017 Jan;23(1):43-50
pubmed: 26993116
Neurology. 2016 Jun 14;86(24):2303-9
pubmed: 27225223
Brain. 2016 Nov 1;139(11):2855-2863
pubmed: 27581073
Lancet Neurol. 2017 Oct;16(10):797-812
pubmed: 28920886